VNDA: Vanda Pharmaceuticals Inc.
2020-12-01 18:22:00
FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome
VNDA: Vanda Pharmaceuticals Inc.
2020-10-26 16:01:00
Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VSJ-110 for Allergic Conjunctivitis
FA:
Earings release- the last earnings where the estimate was higher than 0.05 per share it led to the stock rallying by 40%- unless, the earings surprise is a negative one; we can expect a rally from Vanda Pharmaceuticals.
TA:
Currently been trading in a limited channel- lack of momentum could lead to a dump if earnings estimate is negative or perhaps mean no...
VNDA could be moving in a descending channel before going north again. At this moment is in the upper trendline of the channel.
KL: 16.15
SL: 16.75
TP1: 15.30
TP2: 14.60
Simple probability set up. Triangle downtrend started in 11/2016 and VNDA has only been through one full harmonic trend (wave) ever since. Second wave downward move imminent with RSI confirmation @ 35 and bearish $13 target.
However, aggressive long entry for quick profit ($15 bullish target) especially with upcoming earnings. Upon $15 target, (expected RSI...
VNDA PHARMACEUTICALS is spiking driven by a news event but now it seems going for a correction. If the rising trendline holds i'm expecting a new wave up when this correction is completed.
